$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 04 2021 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 3.75 | 10,000 | 37,500 | 10,000 | |
Jun 04 2021 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 3.75 | 10,000 | 37,500 | 10,000 | |
Mar 05 2021 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Grant | A | 0.00 | 11,125 | 0 | 13,732 | 2.6 K to 13.7 K (+426.74 %) |
Mar 05 2021 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 29,000 | 0 | 135,830 | 106.8 K to 135.8 K (+27.15 %) |
Mar 05 2021 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | CMO and Head of R&D | Grant | A | 0.00 | 11,125 | 0 | 18,527 | 7.4 K to 18.5 K (+150.30 %) |
Nov 12 2020 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Payment of Exercise | F | 0.86 | 1,024 | 881 | 14,952 | 16 K to 15 K (-6.41 %) |
Sep 21 2020 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Grant | A | 0.00 | 3,015 | 0 | 15,639 | 12.6 K to 15.6 K (+23.88 %) |
Sep 21 2020 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Grant | A | 0.00 | 3,015 | 0 | 15,976 | 13 K to 16 K (+23.26 %) |
Sep 21 2020 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 8,543 | 0 | 640,980 | 632.4 K to 641 K (+1.35 %) |
Sep 21 2020 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | CMO and Head of R&D | Grant | A | 0.00 | 3,015 | 0 | 44,410 | 41.4 K to 44.4 K (+7.28 %) |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | STRADER CATHERINE D. | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Jun 17 2020 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 0.85 | 15,000 | 12,768 | 15,000 | |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 1.60 | 2,227 | 3,553 | 117,420 | 119.6 K to 117.4 K (-1.86 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 1.60 | 2,227 | 3,553 | 117,420 | 119.6 K to 117.4 K (-1.86 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 1.60 | 1,513 | 2,421 | 12,624 | 14.1 K to 12.6 K (-10.70 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 1.60 | 1,513 | 2,421 | 12,624 | 14.1 K to 12.6 K (-10.70 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 1.60 | 1,176 | 1,880 | 12,961 | 14.1 K to 13 K (-8.32 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 1.60 | 1,176 | 1,880 | 12,961 | 14.1 K to 13 K (-8.32 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 1.60 | 4,699 | 7,505 | 607,287 | 612 K to 607.3 K (-0.77 %) |
Dec 04 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 1.60 | 4,699 | 7,505 | 607,287 | 612 K to 607.3 K (-0.77 %) |
Nov 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 2.41 | 80,000 | 192,800 | 80,000 | |
Nov 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Option Exercise | A | 2.41 | 80,000 | 192,800 | 80,000 | |
Nov 12 2019 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Option Exercise | A | 2.41 | 80,000 | 192,800 | 80,000 | |
Nov 12 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 2.41 | 218,500 | 526,585 | 218,500 | |
Nov 12 2019 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | CMO and Head of R&D | Option Exercise | A | 2.41 | 80,000 | 192,800 | 80,000 | |
Jun 21 2019 | ACOR | ACORDA THERAPEUTIC ... | STRADER CATHERINE D. | Director | Option Exercise | A | 7.54 | 15,000 | 113,100 | 15,000 | |
Jun 21 2019 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 7.54 | 15,000 | 113,100 | 15,000 | |
Jun 21 2019 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 7.54 | 15,000 | 113,100 | 15,000 | |
Jun 21 2019 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 7.54 | 15,000 | 113,100 | 15,000 | |
Jun 21 2019 | ACOR | ACORDA THERAPEUTIC ... | Kelley John P | Director | Option Exercise | A | 7.54 | 15,000 | 113,100 | 15,000 | |
Jun 21 2019 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 7.54 | 15,000 | 113,100 | 15,000 | |
Jun 21 2019 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 7.54 | 15,000 | 113,100 | 15,000 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Option Exercise | A | 13.51 | 21,355 | 288,506 | 21,355 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 12,813 | 0 | 119,647 | 106.8 K to 119.6 K (+11.99 %) |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Option Exercise | A | 13.51 | 15,075 | 203,663 | 15,075 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Grant | A | 0.00 | 9,045 | 0 | 14,137 | 5.1 K to 14.1 K (+177.63 %) |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Jensen Peder | Director | Option Exercise | A | 13.51 | 10,000 | 135,100 | 10,000 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Option Exercise | A | 13.51 | 15,075 | 203,663 | 15,075 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Grant | A | 0.00 | 9,045 | 0 | 15,639 | 6.6 K to 15.6 K (+137.17 %) |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | A | 13.51 | 42,715 | 577,080 | 42,715 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 25,629 | 0 | 517,136 | 491.5 K to 517.1 K (+5.21 %) |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | CMO and Head of R&D | Option Exercise | A | 13.51 | 15,000 | 202,650 | 15,000 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | CMO and Head of R&D | Option Exercise | A | 13.51 | 15,075 | 203,663 | 15,075 | |
Mar 12 2019 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | CMO and Head of R&D | Grant | A | 0.00 | 9,045 | 0 | 41,395 | 32.4 K to 41.4 K (+27.96 %) |
Feb 25 2019 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Payment of Exercise | F | 13.38 | 953 | 12,751 | 106,834 | 107.8 K to 106.8 K (-0.88 %) |
Feb 25 2019 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 13.18 | 761 | 10,028 | 5,092 | 5.9 K to 5.1 K (-13.00 %) |
Feb 25 2019 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Payment of Exercise | F | 13.38 | 877 | 11,734 | 6,594 | 7.5 K to 6.6 K (-11.74 %) |
Feb 25 2019 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Payment of Exercise | F | 13.38 | 2,027 | 27,121 | 491,507 | 493.5 K to 491.5 K (-0.41 %) |
Feb 01 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.01 | 7,000 | 112,039 | 4,750,219 | 4.8 M to 4.8 M (-0.15 %) |
Jan 28 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.00 | 2,401 | 38,416 | 4,757,219 | 4.8 M to 4.8 M (-0.05 %) |
Jan 28 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.03 | 8,600 | 137,851 | 4,759,620 | 4.8 M to 4.8 M (-0.18 %) |
Jan 24 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.01 | 45,898 | 734,942 | 4,768,220 | 4.8 M to 4.8 M (-0.95 %) |
Jan 24 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.02 | 51,945 | 831,972 | 4,814,118 | 4.9 M to 4.8 M (-1.07 %) |
Jan 22 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.24 | 39,358 | 639,327 | 4,866,063 | 4.9 M to 4.9 M (-0.80 %) |
Jan 22 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.86 | 100,000 | 1,685,550 | 4,905,421 | 5 M to 4.9 M (-2.00 %) |
Jan 17 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.94 | 91,650 | 1,552,414 | 5,005,421 | 5.1 M to 5 M (-1.80 %) |
Jan 17 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.60 | 1,700 | 28,223 | 5,097,071 | 5.1 M to 5.1 M (-0.03 %) |
Jan 15 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 17.40 | 40,392 | 702,788 | 5,098,771 | 5.1 M to 5.1 M (-0.79 %) |
Jan 11 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 17.29 | 87,491 | 1,512,728 | 5,139,163 | 5.2 M to 5.1 M (-1.67 %) |
Jan 11 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 17.05 | 75,000 | 1,278,705 | 5,226,654 | 5.3 M to 5.2 M (-1.41 %) |
Jan 09 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.24 | 59,174 | 960,927 | 5,301,654 | 5.4 M to 5.3 M (-1.10 %) |
Jan 09 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.56 | 75,000 | 1,241,738 | 5,360,828 | 5.4 M to 5.4 M (-1.38 %) |
Jan 07 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.61 | 31,591 | 524,714 | 5,435,828 | 5.5 M to 5.4 M (-0.58 %) |
Jan 07 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 15.74 | 23,616 | 371,645 | 5,467,419 | 5.5 M to 5.5 M (-0.43 %) |
Jan 02 2019 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 14.99 | 52,891 | 792,751 | 5,491,035 | 5.5 M to 5.5 M (-0.95 %) |
Dec 28 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 14.66 | 50,000 | 732,760 | 5,543,926 | 5.6 M to 5.5 M (-0.89 %) |
Dec 28 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 14.66 | 50,000 | 732,820 | 5,593,926 | 5.6 M to 5.6 M (-0.89 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 2,500 | 0 | 107,787 | 105.3 K to 107.8 K (+2.37 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Grant | A | 0.00 | 2,200 | 0 | 5,853 | 3.7 K to 5.9 K (+60.22 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Grant | A | 0.00 | 2,200 | 0 | 5,853 | 3.7 K to 5.9 K (+60.22 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Grant | A | 0.00 | 2,300 | 0 | 7,471 | 5.2 K to 7.5 K (+44.48 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 5,980 | 0 | 493,534 | 487.6 K to 493.5 K (+1.23 %) |
Dec 27 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Grant | A | 0.00 | 2,100 | 0 | 32,350 | 30.3 K to 32.4 K (+6.94 %) |
Dec 26 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 13.24 | 40,506 | 536,097 | 5,643,926 | 5.7 M to 5.6 M (-0.71 %) |
Dec 21 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 14.03 | 40,000 | 561,368 | 5,684,432 | 5.7 M to 5.7 M (-0.70 %) |
Dec 21 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.03 | 1,900 | 30,461 | 5,724,432 | 5.7 M to 5.7 M (-0.03 %) |
Dec 21 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 15.87 | 3,100 | 49,203 | 5,726,332 | 5.7 M to 5.7 M (-0.05 %) |
Dec 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.88 | 30,000 | 506,496 | 5,729,432 | 5.8 M to 5.7 M (-0.52 %) |
Dec 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.97 | 50,000 | 848,445 | 5,759,432 | 5.8 M to 5.8 M (-0.86 %) |
Dec 19 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.49 | 41,853 | 690,102 | 5,809,432 | 5.9 M to 5.8 M (-0.72 %) |
Dec 17 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.15 | 28,796 | 464,978 | 5,851,285 | 5.9 M to 5.9 M (-0.49 %) |
Dec 17 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.27 | 33,061 | 537,760 | 5,880,081 | 5.9 M to 5.9 M (-0.56 %) |
Dec 13 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.30 | 100,000 | 1,629,790 | 5,913,142 | 6 M to 5.9 M (-1.66 %) |
Dec 13 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.30 | 200,000 | 3,259,500 | 6,013,142 | 6.2 M to 6 M (-3.22 %) |
Dec 11 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 19.07 | 35,000 | 667,531 | 6,213,142 | 6.2 M to 6.2 M (-0.56 %) |
Dec 11 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 18.77 | 25,210 | 473,071 | 6,248,142 | 6.3 M to 6.2 M (-0.40 %) |
Dec 07 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 18.43 | 40,711 | 750,340 | 6,273,352 | 6.3 M to 6.3 M (-0.64 %) |
Dec 07 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 20.60 | 3,090 | 63,659 | 6,314,063 | 6.3 M to 6.3 M (-0.05 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Sell | S | 20.52 | 3,067 | 62,947 | 105,287 | 108.4 K to 105.3 K (-2.83 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 20.66 | 4,119 | 85,081 | 1,568 | 5.7 K to 1.6 K (-72.43 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 20.20 | 1,072 | 21,656 | 5,687 | 6.8 K to 5.7 K (-15.86 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Sell | S | 20.55 | 2,493 | 51,232 | 3,653 | 6.1 K to 3.7 K (-40.56 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Sell | S | 20.56 | 753 | 15,478 | 5,171 | 5.9 K to 5.2 K (-12.71 %) |
Dec 06 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.60 | 3,620 | 74,554 | 487,554 | 491.2 K to 487.6 K (-0.74 %) |
Dec 03 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 20.70 | 100,000 | 2,069,500 | 6,317,153 | 6.4 M to 6.3 M (-1.56 %) |
Dec 03 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 20.48 | 75,000 | 1,536,015 | 6,417,153 | 6.5 M to 6.4 M (-1.16 %) |
Dec 03 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 20.20 | 50,000 | 1,009,860 | 6,492,153 | 6.5 M to 6.5 M (-0.76 %) |
Nov 28 2018 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Sell | S | 19.98 | 1,904 | 38,034 | 0 | 1.9 K to 0 (-100.00 %) |
Nov 07 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Payment of Exercise | F | 20.28 | 955 | 19,367 | 108,354 | 109.3 K to 108.4 K (-0.87 %) |
Nov 07 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Payment of Exercise | F | 20.28 | 747 | 15,149 | 6,146 | 6.9 K to 6.1 K (-10.84 %) |
Nov 07 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Payment of Exercise | F | 20.28 | 879 | 17,826 | 5,924 | 6.8 K to 5.9 K (-12.92 %) |
Nov 07 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Payment of Exercise | F | 20.28 | 2,031 | 41,189 | 491,174 | 493.2 K to 491.2 K (-0.41 %) |
Oct 12 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 17.09 | 49,760 | 850,548 | 6,542,153 | 6.6 M to 6.5 M (-0.75 %) |
Oct 12 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.91 | 93,816 | 1,586,757 | 6,591,913 | 6.7 M to 6.6 M (-1.40 %) |
Oct 09 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 16.49 | 56,290 | 928,076 | 6,685,729 | 6.7 M to 6.7 M (-0.83 %) |
Oct 09 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 17.87 | 60,042 | 1,073,197 | 6,742,019 | 6.8 M to 6.7 M (-0.88 %) |
Oct 09 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 17.51 | 37,526 | 657,054 | 6,802,061 | 6.8 M to 6.8 M (-0.55 %) |
Oct 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 18.89 | 37,526 | 708,750 | 6,839,587 | 6.9 M to 6.8 M (-0.55 %) |
Oct 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 19.48 | 56,289 | 1,096,279 | 6,877,113 | 6.9 M to 6.9 M (-0.81 %) |
Oct 04 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 18.89 | 32,649 | 616,704 | 6,933,402 | 7 M to 6.9 M (-0.47 %) |
Oct 03 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | J | 0.00 | 140,904 | 0 | 6,966,051 | 7.1 M to 7 M (-1.98 %) |
Sep 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | President, Intl and ... | Grant | A | 0.00 | 2,500 | 0 | 109,309 | 106.8 K to 109.3 K (+2.34 %) |
Sep 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Grant | A | 0.00 | 2,200 | 0 | 7,506 | 5.3 K to 7.5 K (+41.46 %) |
Sep 12 2018 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief, Bus. Ops & P ... | Grant | A | 0.00 | 2,200 | 0 | 6,893 | 4.7 K to 6.9 K (+46.88 %) |
Sep 12 2018 | ACOR | ACORDA THERAPEUTIC ... | Hindman Andrew A. | Chief Business Offi ... | Grant | A | 0.00 | 2,300 | 0 | 6,803 | 4.5 K to 6.8 K (+51.08 %) |
Sep 12 2018 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Grant | A | 0.00 | 5,980 | 0 | 493,205 | 487.2 K to 493.2 K (+1.23 %) |
Sep 12 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Grant | A | 0.00 | 2,100 | 0 | 30,250 | 28.2 K to 30.3 K (+7.46 %) |
Sep 06 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 27.82 | 13,829 | 384,683 | 7,106,955 | 7.1 M to 7.1 M (-0.19 %) |
Sep 06 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 29.00 | 200 | 5,800 | 7,120,784 | 7.1 M to 7.1 M (0.00 %) |
Sep 06 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 29.41 | 20,256 | 595,658 | 7,120,984 | 7.1 M to 7.1 M (-0.28 %) |
Aug 03 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Option Exercise | M | 16.50 | 6,250 | 103,125 | 18,750 | |
Aug 03 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Sell | S | 24.69 | 6,250 | 154,322 | 28,150 | 34.4 K to 28.2 K (-18.17 %) |
Aug 03 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Buy | M | 16.50 | 6,250 | 103,125 | 34,400 | 28.2 K to 34.4 K (+22.20 %) |
Jul 25 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 28.89 | 11,551 | 333,741 | 7,141,240 | 7.2 M to 7.1 M (-0.16 %) |
Jul 25 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 28.69 | 50,000 | 1,434,550 | 7,152,791 | 7.2 M to 7.2 M (-0.69 %) |
Jul 25 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 28.32 | 25,000 | 708,025 | 7,202,791 | 7.2 M to 7.2 M (-0.35 %) |
Jul 20 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 29.05 | 21,580 | 626,895 | 7,227,791 | 7.2 M to 7.2 M (-0.30 %) |
Jul 20 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 29.15 | 65,700 | 1,914,859 | 7,249,371 | 7.3 M to 7.2 M (-0.90 %) |
Jul 20 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 28.97 | 21,460 | 621,733 | 7,315,071 | 7.3 M to 7.3 M (-0.29 %) |
Jul 17 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.05 | 8,199 | 246,354 | 7,336,531 | 7.3 M to 7.3 M (-0.11 %) |
Jul 17 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.04 | 25,000 | 750,978 | 7,344,730 | 7.4 M to 7.3 M (-0.34 %) |
Jul 17 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.00 | 100 | 3,000 | 7,369,730 | 7.4 M to 7.4 M (0.00 %) |
Jul 10 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.27 | 8,226 | 248,980 | 7,369,830 | 7.4 M to 7.4 M (-0.11 %) |
Jul 10 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.27 | 32,128 | 972,550 | 7,378,056 | 7.4 M to 7.4 M (-0.43 %) |
Jul 10 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.70 | 160,000 | 4,911,264 | 7,410,184 | 7.6 M to 7.4 M (-2.11 %) |
Jul 05 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.10 | 27,093 | 815,380 | 7,570,184 | 7.6 M to 7.6 M (-0.36 %) |
Jul 05 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.01 | 3,400 | 102,050 | 7,597,277 | 7.6 M to 7.6 M (-0.04 %) |
Jul 05 2018 | ACOR | ACORDA THERAPEUTIC ... | SCOPIA CAPITAL MANAGEMENT LP | 10% Owner | Sell | S | 30.06 | 35,889 | 1,078,870 | 7,600,677 | 7.6 M to 7.6 M (-0.47 %) |
Jul 03 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Sell | S | 29.87 | 2,859 | 85,412 | 28,150 | 31 K to 28.2 K (-9.22 %) |
Jul 03 2018 | ACOR | ACORDA THERAPEUTIC ... | BLANK BURKHARD | Chief Medical Offic ... | Sell | S | 29.26 | 2,141 | 62,638 | 31,009 | 33.2 K to 31 K (-6.46 %) |
Jul 02 2018 | ACOR | ACORDA THERAPEUTIC ... | Sabella Lauren M | Chief Commercial Of ... | Sell | S | 27.84 | 5,859 | 163,140 | 5,306 | 11.2 K to 5.3 K (-52.48 %) |
Jun 29 2018 | ACOR | ACORDA THERAPEUTIC ... | STRADER CATHERINE D. | Director | Option Exercise | A | 28.15 | 15,000 | 422,250 | 15,000 | |
Jun 29 2018 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 28.15 | 15,000 | 422,250 | 15,000 | |
Jun 29 2018 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 28.15 | 15,000 | 422,250 | 15,000 | |
Jun 29 2018 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 28.15 | 15,000 | 422,250 | 15,000 |